Immune Response Archives - tgiHealthCareerp

Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis

05/11/2021 a, antibiotic, Immune Response

A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis

Health News

Candidate coronavirus vaccines show promising results in early animal testing

04/18/2021 Antigen, Bacteria, coronavirus, diarrhea, DNA, e-coli, Genes, genome, Genomic, Immune Response, immune system, immunology, laboratory, Manufacturing, Medicine, pandemic, Plasmid, research, SARS, SARS-CoV-2, vaccine, Veterinary, virus

A candidate vaccine that could provide protection against the COVID-19 virus and other coronaviruses has shown promising results in early

Health News

Novel immunotherapy approach may offer therapeutic advantages for melanoma

04/12/2021 antibody, cancer, Cancer Treatment, Cell, DNA, hospital, Immune Response, melanoma, research, RNA, Tumor

In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can

Health News

L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

04/12/2021 ACE2, Antigen, binding affinity, blood, coronavirus, Coronavirus Disease COVID-19, Human Leukocyte Antigen, Immune Response, Leukocyte, Mutation, protein, Protein Stability, Public Health, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome

Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found

Health News

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

04/06/2021 ACE2, Angiotensin, antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, Glycine, Glycoprotein, Heparin, Immune Response, immunization, Nanoparticle, Nanoparticles, protein, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Health News

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

03/15/2021 antibodies, Cell, Chemokines, coronavirus, Cytokines, fever, Immune Response, inflammation, Intracellular, Lipids, Macrophage, Nanoparticle, Nanoparticles, Necroptosis, Nucleoside, Pain, peptides, Preclinical, protein, research, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine

Lipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and

Health News

Researchers confirm new drug development route for treating multiple sclerosis, asthma

03/10/2021 Animal Model, anti inflammatory, asthma, Brain, Cell, Cell Signaling, chronic, Education, efficacy, fish, genome, Immune Response, in vivo, laboratory, molecule, multiple sclerosis, peptides, Preclinical, research, sclerosis, toxicology, Toxins

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic

Health Problems

What is Granulomatosis with Polyangiitis?

01/31/2021 antibodies, Autoimmune Disease, biopsy', blood, blood vessel, Blood Vessels, Capillaries, Cell, Drugs, Granulomatosis with Polyangiitis, Imaging, Immune Response, inflammation, lungs, Neutrophils, Pain, steroid, Vasculitis, Wegener's Granulomatosis, White Blood Cell

Skip to Why does GPA develop? Symptoms of GPA How is GPA diagnosed? How is GPA treated? Risk Factors for